Olfactory dysfunction could be the sign of acquired or degenerative diseases. The loss of the sense can be caused by a damage in the nasal structure (olfactory epithelium) or a neuro inflammation/degeneration in the superior olfactory pathway. The understanding of the origin of the smell alteration would be desirable for appropriate management of the problem. Unfortunately, clinical investigations do not always allow to define the exact cause.

Investigational drugs for the treatment of olfactory dysfunction

A. DI STADIO
Primo
Methodology
;
IGNAZIO LA MANTIA
Ultimo
Validation
2022-01-01

Abstract

Olfactory dysfunction could be the sign of acquired or degenerative diseases. The loss of the sense can be caused by a damage in the nasal structure (olfactory epithelium) or a neuro inflammation/degeneration in the superior olfactory pathway. The understanding of the origin of the smell alteration would be desirable for appropriate management of the problem. Unfortunately, clinical investigations do not always allow to define the exact cause.
2022
SMELL LOSS, LUT, LUTEOLIN, PEA, PEALUT, CORTISONE, NEUROEPITHELIUM, NEUROINFLAMMATION, OLFACTORY, OLFACTORY BULBS, OLFACTORY CORTEX, VITAMIN A
File in questo prodotto:
File Dimensione Formato  
Expert opinion drugs for anosmia.iposmia.pdf

solo gestori archivio

Descrizione: articolo
Tipologia: Versione Editoriale (PDF)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.8 MB
Formato Adobe PDF
2.8 MB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/535759
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact